TY  - GEN
AU  - Melemedjian,Ohannes K
AU  - Asiedu,Marina N
AU  - Tillu,Dipti V
AU  - Sanoja,Raul
AU  - Yan,Jin
AU  - Lark,Arianna
AU  - Khoutorsky,Arkady
AU  - Johnson,Jessica
AU  - Peebles,Katherine A
AU  - Lepow,Talya
AU  - Sonenberg,Nahum
AU  - Dussor,Gregory
AU  - Price,Theodore J
TI  - Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain
SN  - 1744-8069
PY  - 2011///1124
KW  - AMP-Activated Protein Kinase Kinases
KW  - Action Potentials
KW  - drug effects
KW  - Animals
KW  - Blotting, Western
KW  - Disease Models, Animal
KW  - Enzyme Activators
KW  - pharmacology
KW  - Eukaryotic Initiation Factor-4F
KW  - biosynthesis
KW  - Hyperalgesia
KW  - complications
KW  - Male
KW  - Mice
KW  - Mice, Inbred ICR
KW  - Molecular Targeted Therapy
KW  - Neuralgia
KW  - drug therapy
KW  - Protein Biosynthesis
KW  - Protein Kinases
KW  - metabolism
KW  - Rats
KW  - Rats, Sprague-Dawley
KW  - Sciatic Nerve
KW  - Sensory Receptor Cells
KW  - Signal Transduction
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1744-8069-7-70
ER  -